医療用外骨格(Medical Exoskeleton)の世界市場:タイプ別2023年予測
Medical Exoskeleton Market by Component (Hardware (Sensor, Actuator, Control System, Power Source), Software), Type (Powered, Passive), Extremities (Lower, Upper) & Mobility (Mobile, Stationary) - Global Forecast to 2023
- 出版元:MarketsandMarkets出版元について
- 発行年:2018年7月
- 定価 Single User License(1名様ライセンス)US$5,650(米国ドル)/Multi User License(5名様)$6,650 /Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算(お見積り日TTSレート)となります。
- 納品形態:PDF by Email
- 当調査レポートは英文 117ページになります。
- 商品コード:MAM1183
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
医療用外骨格(Medical Exoskeleton)の世界市場は今後高成長が期待され、その市場規模は2018年段階で推計1億1670万ドル、2023年には5億7160万ドル市場に拡大するとレポートでは予測しています。身体障害者のより効果的なリハビリアプローチへのニーズ、外骨格技術開発に向けた企業間の提携・契約、一部の国における外骨格への保険適用への動き、などは同市場のドライバーと見ることができるでしょう。
当レポートでは、2023年に至る医療用外骨格の世界市場予測(市場規模US$)、コンポーネント別市場(ハードウェア各種、ソフトウェア)、タイプ別市場(パワードスーツ、パッシブ外骨格)、モビリティ別市場(据え置き型メディカル外骨格、モバイル型メディカル外骨格)、四肢別市場(下肢メディカル外骨格、上肢メディカル外骨格
)、主要国地域別市場など、詳細な市場予測データと分析を掲載しています。また市場分析、競合状況、主要メーカー企業12社プロフィール動向などの情報も交えて、医療用外骨格市場の現在と今後展開を予測分析していきます。
【レポート構成概要】
◆ 医療用外骨格の世界市場予測2016-2023年
・市場規模(US$)
・数量(Units)
◆ コンポーネント別、市場-2023年
ハードウェア
・センサ
・アクチュエータ
・動力源
・制御システム
・その他ハードウェアコンポーネント
ソフトウェア
※(市場規模US$)
◆ タイプ別、市場-2023年
・パワードスーツ
・パッシブ外骨格
※(市場規模US$)
◆モビリティ別、市場-2023年
・据え置き型メディカル外骨格
・モバイル型メディカル外骨格
※(市場規模US$)
◆上肢/下肢別、市場-2023年
・下肢メディカル外骨格
・上肢メディカル外骨格
※(市場規模US$)、(数量Units)
◆主要国地域別市場-2023年
北米
・米国、カナダ
欧州
・英国、ドイツ、フランス
・その他欧州
アジア
その他地域
※ 国地域にコンポーネント別、タイプ別、モビリティ別、上下肢別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・競合状況
◆ 医療用外骨格の主要企業プロフィール動向
・CYBERDYNE株式会社
・EKSO BIONICS HOLDINGS
・REWALK ROBOTICS
・BIONIK LABORATORIES
・REX BIONICS
・PARKER HANNIFIN
・B-TEMIA
・BIONESS
・HOCOMA AG (A SUBSIDIARY OF DIH TECHNOLOGIES)
・WEARABLE ROBOTICS
・GOGOA MOBILITY ROBOTS
・EXOATLET
(全117頁)
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
英文詳細目次(table of contents)
【原文詳細目次】
Medical Exoskeleton Market by Component (Hardware (Sensor, Actuator, Control System, Power Source), Software), Type (Powered, Passive), Extremities (Lower, Upper) & Mobility (Mobile, Stationary) - Global Forecast to 2023
Table of Contents
1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.1.1 SECONDARY DATA 18
2.1.1.1 Key data from secondary sources 18
2.1.2 PRIMARY DATA 19
2.1.2.1 Key data from primary sources 19
2.1.2.2 Key industry insights 20
2.2 MARKET SIZE ESTIMATION 21
2.3 DATA TRIANGULATION 23
2.4 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 29
4.1 MEDICAL EXOSKELETON: MARKET OVERVIEW 29
4.2 MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2018 VS 2023 (USD MILLION) 30
4.3 EUROPE: MEDICAL EXOSKELETON MARKET, BY HARDWARE TYPE & COUNTRY 31
4.4 MEDICAL EXOSKELETON MARKET, BY EXTREMITY 32
4.5 MEDICAL EXOSKELETON MARKET: GEOGRAPHIC SNAPSHOT 32
5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 34
5.2.1.1 Increasing number of people with physical disabilities and subsequent growth in the demand for effective rehabilitation approaches 34
5.2.1.2 Agreements and collaborations among companies and research organizations for the development of the exoskeleton technology 36
5.2.1.3 Increasing insurance coverage for medical exoskeletons in several countries 36
5.2.2 OPPORTUNITIES 37
5.2.2.1 Introduction of soft actuators 37
5.2.3 CHALLENGES 37
5.2.3.1 High cost of medical exoskeletons 37
6 MEDICAL EXOSKELETON MARKET, BY COMPONENT 38
6.1 INTRODUCTION 39
6.2 HARDWARE 40
6.2.1 SENSORS 41
6.2.2 ACTUATORS 41
6.2.3 POWER SOURCES 42
6.2.4 CONTROL SYSTEMS 42
6.2.5 OTHER HARDWARE COMPONENTS 43
6.3 SOFTWARE 44
7 MEDICAL EXOSKELETON MARKET, BY TYPE 45
7.1 INTRODUCTION 46
7.2 POWERED EXOSKELETON 47
7.3 PASSIVE EXOSKELETON 47
8 MEDICAL EXOSKELETON MARKET, BY MOBILITY 49
8.1 INTRODUCTION 50
8.2 STATIONARY MEDICAL EXOSKELETONS 51
8.3 MOBILE MEDICAL EXOSKELETONS 51
9 MEDICAL EXOSKELETON MARKET, BY EXTREMITY 53
9.1 INTRODUCTION 54
9.2 LOWER EXTREMITY MEDICAL EXOSKELETONS 55
9.3 UPPER EXTREMITY MEDICAL EXOSKELETONS 56
10 MEDICAL EXOSKELETON MARKET, BY REGION 57
10.1 INTRODUCTION 58
10.2 NORTH AMERICA 59
10.2.1 US 62
10.2.2 CANADA 63
10.3 EUROPE 65
10.3.1 UK 69
10.3.2 GERMANY 70
10.3.3 FRANCE 72
10.3.4 REST OF EUROPE (ROE) 74
10.4 ASIA 76
10.5 REST OF THE WORLD 78
11 COMPETITIVE LANDSCAPE 81
11.1 OVERVIEW 81
11.2 MARKET SHARE RANKING 82
11.3 COMPETITIVE SITUATIONS AND TRENDS 83
11.3.1 PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS 83
11.3.2 AGREEMENTS, COLLABORATIONS, ALLIANCES, JOINT VENTURES, CONTRACTS, AND PARTNERSHIPS 84
11.3.3 MERGERS AND ACQUISITIONS 84
11.3.4 EXPANSIONS 85
12 COMPANY PROFILES 86
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 CYBERDYNE 86
12.2 EKSO BIONICS HOLDINGS 89
12.3 REWALK ROBOTICS 92
12.4 BIONIK LABORATORIES 95
12.5 REX BIONICS 98
12.6 PARKER HANNIFIN 99
12.7 B-TEMIA 101
12.8 BIONESS 103
12.9 HOCOMA AG (A SUBSIDIARY OF DIH TECHNOLOGIES) 104
12.10 WEARABLE ROBOTICS 106
12.11 GOGOA MOBILITY ROBOTS 107
12.12 EXOATLET 108
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
13 APPENDIX 109
LIST OF TABLES
TABLE 1 COST OF MEDICAL EXOSKELETONS 37
TABLE 2 MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2016–2023 (USD MILLION) 39
TABLE 3 MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE,
2016–2023 (USD MILLION) 40
TABLE 4 MEDICAL EXOSKELETON HARDWARE MARKET, BY REGION,
2016–2023 (USD MILLION) 40
TABLE 5 SENSORS MARKET, BY REGION, 2016–2023 (USD MILLION) 41
TABLE 6 ACTUATORS MARKET, BY REGION, 2016–2023 (USD MILLION) 41
TABLE 7 POWER SOURCES MARKET, BY REGION, 2016–2023 (USD MILLION) 42
TABLE 8 CONTROL SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION) 42
TABLE 9 OTHER HARDWARE COMPONENTS, BY REGION, 2016–2023 (USD MILLION) 43
TABLE 10 MEDICAL EXOSKELETON SOFTWARE MARKET, BY REGION,
2016–2023 (USD MILLION) 44
TABLE 11 MEDICAL EXOSKELETON MARKET, BY TYPE, 2016–2023 (USD MILLION) 46
TABLE 12 POWERED EXOSKELETON MARKET, BY REGION, 2016–2023 (USD MILLION) 47
TABLE 13 PASSIVE EXOSKELETON MARKET, BY REGION, 2016–2023 (USD MILLION) 48
TABLE 14 MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2016–2023 (USD MILLION) 50
TABLE 15 STATIONARY MEDICAL EXOSKELETONS MARKET, BY REGION,
2016–2023 (USD MILLION) 51
TABLE 16 MOBILE MEDICAL EXOSKELETONS MARKET, BY REGION,
2016–2023 (USD MILLION) 52
TABLE 17 MEDICAL EXOSKELETON MARKET, BY EXTREMITY, 2016–2023 (USD MILLION) 54
TABLE 18 MEDICAL EXOSKELETON MARKET, BY EXTREMITY, 2016–2023 (UNITS) 55
TABLE 19 LOWER EXTREMITY MEDICAL EXOSKELETONS MARKET, BY REGION,
2016–2023 (USD MILLION) 55
TABLE 20 UPPER EXTREMITY MEDICAL EXOSKELETONS MARKET, BY REGION,
2016–2023 (USD MILLION) 56
TABLE 21 MEDICAL EXOSKELETON MARKET, BY REGION, 2016–2023 (USD MILLION) 58
TABLE 22 MEDICAL EXOSKELETON MARKET, BY REGION, 2016–2023 (UNITS) 58
TABLE 23 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 60
TABLE 24 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2016–2023 (USD MILLION) 60
TABLE 25 NORTH AMERICA: MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE,
2016–2023 (USD MILLION) 60
TABLE 26 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY TYPE,
2016–2023 (USD MILLION) 61
TABLE 27 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2016–2023 (USD MILLION) 61
TABLE 28 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY EXTREMITY,
2016–2023 (USD MILLION) 61
TABLE 29 US: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2016–2023 (USD MILLION) 62
TABLE 30 US: MEDICAL EXOSKELETON MARKET, BY TYPE, 2016–2023 (USD MILLION) 62
TABLE 31 US : MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2016–2023 (USD MILLION) 63
TABLE 32 US: MEDICAL EXOSKELETON MARKET, BY EXTREMITY, 2016–2023 (USD MILLION) 63
TABLE 33 CANADA: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2016–2023 (USD MILLION) 64
TABLE 34 CANADA: MEDICAL EXOSKELETON MARKET, BY TYPE, 2016–2023 (USD MILLION) 64
TABLE 35 CANADA: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2016–2023 (USD MILLION) 64
TABLE 36 CANADA: MEDICAL EXOSKELETON MARKET, BY EXTREMITY,
2016–2023 (USD MILLION) 65
TABLE 37 EUROPE: MEDICAL EXOSKELETON MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 67
TABLE 38 EUROPE: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2016–2023 (USD MILLION) 67
TABLE 39 EUROPE: MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE, 2016–2023 (USD MILLION) 67
TABLE 40 EUROPE: MEDICAL EXOSKELETON MARKET, BY TYPE, 2016–2023 (USD MILLION) 68
TABLE 41 EUROPE: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2016–2023 (USD MILLION) 68
TABLE 42 EUROPE: MEDICAL EXOSKELETON MARKET, BY EXTREMITY,
2016–2023 (USD MILLION) 68
TABLE 43 UK: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2016–2023 (USD MILLION) 69
TABLE 44 UK: MEDICAL EXOSKELETON MARKET, BY TYPE, 2016–2023 (USD MILLION) 69
TABLE 45 UK: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2016–2023 (USD MILLION) 70
TABLE 46 UK: MEDICAL EXOSKELETON MARKET, BY EXTREMITY, 2016–2023 (USD MILLION) 70
TABLE 47 GERMANY: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2016–2023 (USD MILLION) 71
TABLE 48 GERMANY: MEDICAL EXOSKELETON MARKET, BY TYPE,
2016–2023 (USD MILLION) 71
TABLE 49 GERMANY: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2016–2023 (USD MILLION) 72
TABLE 50 GERMANY: MEDICAL EXOSKELETON MARKET, BY EXTREMITY,
2016–2023 (USD MILLION) 72
TABLE 51 FRANCE: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2016–2023 (USD MILLION) 73
TABLE 52 FRANCE: MEDICAL EXOSKELETON MARKET, BY TYPE, 2016–2023 (USD MILLION) 73
TABLE 53 FRANCE: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2016–2023 (USD MILLION) 73
TABLE 54 FRANCE: MEDICAL EXOSKELETON MARKET, BY EXTREMITY,
2016–2023 (USD MILLION) 74
TABLE 55 ROE: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2016–2023 (USD MILLION) 74
TABLE 56 ROE: MEDICAL EXOSKELETON MARKET, BY TYPE, 2016–2023 (USD MILLION) 75
TABLE 57 ROE: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2016–2023 (USD MILLION) 75
TABLE 58 ROE: MEDICAL EXOSKELETON MARKET, BY EXTREMITY,
2016–2023 (USD MILLION) 75
TABLE 59 ASIA: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2016–2023 (USD MILLION) 76
TABLE 60 ASIA: MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE,
2016–2023 (USD MILLION) 77
TABLE 61 ASIA: MEDICAL EXOSKELETON MARKET, BY TYPE, 2016–2023 (USD MILLION) 77
TABLE 62 ASIA: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2016–2023 (USD MILLION) 77
TABLE 63 ASIA: MEDICAL EXOSKELETON MARKET, BY EXTREMITY,
2016–2023 (USD MILLION) 78
TABLE 64 ROW: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2016–2023 (USD MILLION) 79
TABLE 65 ROW: MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE,
2016–2023 (USD MILLION) 79
TABLE 66 ROW: MEDICAL EXOSKELETON MARKET, BY TYPE, 2016–2023 (USD MILLION) 79
TABLE 67 ROW: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2016–2023 (USD MILLION) 80
TABLE 68 ROW: MEDICAL EXOSKELETON MARKET, BY EXTREMITY,
2016–2023 (USD MILLION) 80
TABLE 69 MARKET RANKING: MEDICAL EXOSKELETON MARKET (2017) 82
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 17
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 20
FIGURE 3 MARKET ESTIMATION: BOTTOM-UP APPROACH 21
FIGURE 4 MARKET SIZE: TOP-DOWN APPROACH 22
FIGURE 5 DATA TRIANGULATION METHODOLOGY 23
FIGURE 6 MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2018–2023 (USD MILLION) 25
FIGURE 7 MEDICAL EXOSKELETON MARKET, BY TYPE, 2018–2023 (USD MILLION) 26
FIGURE 8 MEDICAL EXOSKELETON MARKET, BY EXTREMITY, 2018-2023 (USD MILLION) 26
FIGURE 9 MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2018–2023 (USD MILLION) 27
FIGURE 10 MEDICAL EXOSKELETON MARKET: GEOGRAPHICAL SNAPSHOT 28
FIGURE 11 INCREASING DEMAND FOR EFFECTIVE REHABILITATION APPROACHES IS DRIVING MARKET GROWTH 29
FIGURE 12 HARDWARE IS PROJECTED TO DOMINATE THE MEDICAL EXOSKELETON MARKET
IN 2018 30
FIGURE 13 ACTUATORS TO HOLD THE LARGEST SHARE OF THE MEDICAL EXOSKELETON HARDWARE MARKET IN 2018 31
FIGURE 14 UPPER EXTREMITY EXOSKELETONS TO GROW AT THE HIGHEST CAGR FROM 2018 TO 2023 32
FIGURE 15 ASIA TO BE THE FASTEST-GROWING REGIONAL SEGMENT DURING THE FORECAST PERIOD 32
FIGURE 16 MEDICAL EXOSKELETON MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES 33
FIGURE 17 AGING POPULATION, BY REGION, 2015 VS. 2030 34
FIGURE 18 PERCENTAGE OF DISABLED PEOPLE IN THE TOTAL POPULATION OF THE US,
2011–2016 35
FIGURE 19 US: PERCENTAGE OF DISABLED PEOPLE, BY AGE GROUP, 2016 35
FIGURE 20 HARDWARE SEGMENT TO DOMINATE THE MEDICAL EXOSKELETON MARKET DURING THE FORECAST PERIOD 39
FIGURE 21 POWERED EXOSKELETON SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 46
FIGURE 22 MOBILE MEDICAL EXOSKELETONS TO DOMINATE THE MEDICAL EXOSKELETON MARKET DURING THE FORECAST PERIOD 50
FIGURE 23 LOWER EXTREMITY MEDICAL EXOSKELETONS SEGMENT TO DOMINATE THE MEDICAL EXOSKELETON MARKET DURING THE FORECAST PERIOD 54
FIGURE 24 NORTH AMERICA: MEDICAL EXOSKELETON MARKET SNAPSHOT 59
FIGURE 25 EUROPE: MEDICAL EXOSKELETON MARKET SNAPSHOT 66
FIGURE 26 KEY PLAYERS ADOPTED ORGANIC AND INORGANIC GROWTH STRATEGIES BETWEEN JANUARY 2015 AND JUNE 2018 81
FIGURE 27 MARKET EVOLUTION FRAMEWORK 82
FIGURE 28 CYBERDYNE: COMPANY SNAPSHOT (2017) 86
FIGURE 29 COMPANY SNAPSHOT: EKSO BIONICS (2017) 89
FIGURE 30 COMPANY SNAPSHOT: REWALK ROBOTICS (2017) 92
FIGURE 31 COMPANY SNAPSHOT: PARKER HANNIFIN (2017) 99
プレスリリース
プレスリリース
当レポートのプレスリリースは発行されておりません。